RAP 0.00% 20.5¢ resapp health limited

it seems unlikely that would have fixed the issue of...

  1. 388 Posts.
    it seems unlikely that would have fixed the issue of bronchodilator pre-cough. That usually is diluted in saline and the saline itself may have loosened up secretions in some, even leading to expectoration/swallowing, therefore altering the sound signature in ways other than muscle relaxation.

    In other words, a question is, could the neb alter the sound profile of non-asthmatic LRT disease?

    Actually, a sideline in acoustic data gathering that would be useful is cough pre and post "treatment"

    But with 20/20 hindsight it is hard to disagree with a small but statistically meaningful blinded study.

    Bigger issue may be the problems of noise artefact and voluntary versus involuntary cough. Both should be subject to rigorous troubleshooting.

    Might be a nice masters project for UQ biomeds ... is there a difference between the natural cough of an irritated airway or one trying to clear secretion and a voluntarily produced one? Good one for the null hypothesis.

    Time critical issues now, but essential to have confidence in I would have thought before the 2nd US paediatric study.
    Last edited by MightyChina: 11/08/17
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.